KLK3 and prostate carcinoma: This score should not be utilized alone to alter decision making but rather combined with the patient’s age, PSA, clinical stage, percent positive cores, Gleason score, and AUA risk category to predict 10-year prostate cancer-specific mortality risk [31,32].